CompanyGraph
Kestra Medical Technologies, Ltd.
KMTS · United States
kestramedical.comFinancials as of FY2025–FY2026
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.43B, above the global median of $1.15B
- PositionOperating margin is -137.4%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2025, balance sheet FY2026, cash-flow statement FY2026. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
1.43BUSDvs all stocks (USD)
Revenue (TTM)
95.13MUSDvs all stocks (USD)
Profit Margin
-138.35%vs Medical Instruments & Supplies peers
52-Week Change
46.84%vs all stocks
Market Capitalization
1.43BUSDvs all stocks (USD)
Enterprise Value
1.28BUSDvs all stocks (USD)
Forward P/E
-12.09xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
15.04xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
5.49xvs Medical Instruments & Supplies peers
Enterprise to Revenue
13.47xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-10.17xvs Medical Instruments & Supplies peers
Gross Margin
54.76%vs Medical Instruments & Supplies peers
Profit Margin
-138.35%vs Medical Instruments & Supplies peers
Operating Margin
-137.38%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-25.75%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-56.60%vs Medical Instruments & Supplies peers
Revenue (TTM)
95.13MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.76USDUpdated Jul 19, 2026Quarterly Revenue Growth
66.20%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
48.86MUSDvs all stocks (USD)
EBITDA (TTM)
-126.03MUSDvs all stocks (USD)
Net Income (TTM)
-131.61MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
66.18%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
-81.70MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-75.76MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
59.81MUSDFY2025 · Apr 30, 2025Cost of Goods Sold
35.60MUSDFY2025 · Apr 30, 2025Gross Profit
24.21MUSDFY2025 · Apr 30, 2025Operating Income
-106.38MUSDvs all stocks (USD)
Pre-tax Income
-113.68MUSDFY2025 · Apr 30, 2025Income Tax Expense
135.00KUSDFY2025 · Apr 30, 2025Net Income
-113.81MUSDFY2025 · Apr 30, 2025EBIT
-105.94MUSDFY2025 · Apr 30, 2025EBITDA (Income Statement)
-95.33MUSDFY2025 · Apr 30, 2025Research & Development
15.65MUSDFY2025 · Apr 30, 2025Selling, General & Administrative
114.94MUSDFY2025 · Apr 30, 2025Non-operating Interest Income
3.20MUSDFY2025 · Apr 30, 2025Non-operating Interest Expense
7.73MUSDFY2025 · Apr 30, 2025EPS (Basic)
-5.13USDFY2025 · Apr 30, 2025EPS (Diluted)
-5.13USDFY2025 · Apr 30, 2025Basic Shares Outstanding
24.58MSharesFY2025 · Apr 30, 2025Diluted Shares Outstanding
24.58MSharesFY2025 · Apr 30, 2025Net Income from Continuing Operations
-113.81MUSDFY2025 · Apr 30, 2025Operating Cash Flow
-92.75MUSDFY2026 · Apr 30, 2026Free Cash Flow
-128.17MUSDFY2026 · Apr 30, 2026Cash & Cash Equivalents (End of Period)
100.04MUSDFY2026 · Apr 30, 2026Income Tax Paid
13.00KUSDFY2026 · Apr 30, 2026Interest Paid
5.64MUSDFY2026 · Apr 30, 2026Starting Profit (CF Statement)
-131.61MUSDFY2026 · Apr 30, 2026Depreciation & Amortization
8.71MUSDFY2026 · Apr 30, 2026Deferred Taxes (CF)
166.00KUSDFY2026 · Apr 30, 2026Stock-based Compensation
33.64MUSDFY2026 · Apr 30, 2026Other Non-cash Items
2.20MUSDFY2026 · Apr 30, 2026Change in Accounts Receivable (CF)
-9.06MUSDFY2026 · Apr 30, 2026Change in Accounts Payable (CF)
4.30MUSDFY2026 · Apr 30, 2026Change in Other Assets/Liabilities
-1.10MUSDFY2026 · Apr 30, 2026Capital Expenditures
-35.42MUSDFY2026 · Apr 30, 2026Other Investing Activity
184.00KUSDFY2026 · Apr 30, 2026Net Investing Cash Flow
-35.24MUSDFY2026 · Apr 30, 2026Common Dividends Paid
-323.00KUSDFY2026 · Apr 30, 2026Other Financing Charges
-2.47MUSDFY2026 · Apr 30, 2026Net Financing Cash Flow
146.50MUSDFY2026 · Apr 30, 2026Shares Outstanding
58.38MSharesUpdated Jul 19, 2026Float Shares
33.00MSharesUpdated Jul 19, 2026Shares Short
3.36MSharesUpdated Jul 19, 2026Short Ratio
8.56daysvs all stocks
Short % of Shares Outstanding
10.88%vs all stocks
% Held by Insiders
5.29%vs all stocks
% Held by Institutions
102.47%vs all stocks
Total Cash (MRQ)
196.43MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.35USDUpdated Jul 19, 2026Total Debt (MRQ)
46.79MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1802xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
4.41xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
4.45USDUpdated Jul 19, 2026Total Assets
358.46MUSDvs all stocks (USD)
Total Current Assets
222.36MUSDFY2026 · Apr 30, 2026Total Liabilities
98.81MUSDFY2026 · Apr 30, 2026Total Non-current Assets
136.11MUSDFY2026 · Apr 30, 2026Total Non-current Liabilities
48.44MUSDFY2026 · Apr 30, 2026Total Current Liabilities
50.37MUSDFY2026 · Apr 30, 2026Cash & Cash Equivalents
99.71MUSDFY2026 · Apr 30, 2026Accounts Receivable
14.54MUSDFY2026 · Apr 30, 2026Inventory
6.71MUSDFY2026 · Apr 30, 2026Accounts Payable
27.30MUSDFY2026 · Apr 30, 2026Short-term Debt
31.00KUSDFY2026 · Apr 30, 2026Long-term Debt
46.76MUSDFY2026 · Apr 30, 2026Other Non-current Liabilities
306.00KUSDFY2026 · Apr 30, 2026Common Stock (Book)
58.38MUSDFY2026 · Apr 30, 2026Retained Earnings
-651.86MUSDFY2026 · Apr 30, 2026Total Shareholders' Equity
259.66MUSDvs all stocks (USD)
52-Week Low
14.10USDUpdated Jul 19, 202652-Week High
30.00USDUpdated Jul 19, 202652-Week Change
46.84%vs all stocks
50-Day MA
22.18USDUpdated Jul 19, 2026200-Day MA
23.59USDUpdated Jul 19, 2026Avg 10-Day Volume
502.50KSharesUpdated Jul 19, 2026Avg 30-Day Volume
444.00KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-2.43USDUpdated Jul 19, 2026Other Income / Expense
-2.77MUSDFY2025 · Apr 30, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -137.4%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: -1.37Industry median: 0.12Industry P5: -0.16Peers compared: 65.00
Profit margin is -138.4%, lower than 95% of its Medical Instruments & Supplies peers (median 8.2%)Significant
Profit margin: -1.38Industry median: 0.08Industry P5: -0.45Peers compared: 65.00
Return on equity is -56.6%, lower than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: -0.57Industry median: 0.06Industry P5: -0.46Peers compared: 65.00
Return on assets is -25.7%, lower than 95% of its Medical Instruments & Supplies peers (median 4%)Significant
Return on assets: -0.26Industry median: 0.04Industry P5: -0.17Peers compared: 65.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.55Profit Margin: -1.38
Financial Health
Altman Z-Score 6.94: safe zoneNotable
Altman Z-Score: 6.94
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.43B, above the global median of $1.15BNotable
Market cap (USD): 1,431,072,976Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Weifu High Technology Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Polyrocks Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Beijing Onmicro Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Mitra Keluarga Karyasehat Tbk
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Uni-Trend Technology Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Biolife Solutions Inc.
Tier 1ProductionThroughput-Bound ConversionRule
Amprius Technologies Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Guangzhou Sanfu New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Privi Speciality Chemicals Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Taihan Fiberoptics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule